Updated Analysis of Bellini, a Phase 3 Study of Venetoclax or Placebo in Combination with Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma

被引:30
作者
Moreau, Philippe [1 ]
Harrison, Simon [2 ]
Cavo, Michele [3 ]
De La Rubia, Javier [4 ,5 ]
Popat, Rakesh [6 ]
Gasparetto, Cristina [7 ]
Hungria, Vania T. M. [8 ]
Salwender, Hans [9 ]
Suzuki, Kenshi [10 ]
Kim, Inho [11 ]
Gay, Francesca [12 ]
Mikala, Gabor [13 ]
Punnoose, Elizabeth A. [14 ]
Hong, Wan-Jen [14 ]
Sood, Anjla [15 ]
Jalaluddin, Muhammad [15 ]
Ross, Jeremy A. [15 ]
Ward, James E. [15 ]
Maciag, Paulo C. [15 ]
Kumar, Shaji K. [16 ]
机构
[1] Univ Hosp Hotel Dieu, Clin Hematol, Nantes, France
[2] Peter MacCallum Canc Ctr, Clin Haematol, Melbourne, Vic, Australia
[3] Univ Bologna, Seragnoli Inst Hematol, Dept Expt Diagnost & Specialty Med, Bologna, Italy
[4] Catholic Univ Valencia, Sch Med & Dent, Dept Hematol, Internal Med, Valencia, Spain
[5] Hosp Doctor Peset, Valencia, Spain
[6] Univ Coll London Hosp NHS Fdn Trust, London, England
[7] Duke Univ, Med Ctr, Durham, NC USA
[8] Clin Sao Germano, Hematol, Sao Paulo, Brazil
[9] Altona & AK St Georg, Asklepios Tumorzentrum Hamburg, Hamburg, Germany
[10] Japanese Red Cross Med Ctr, Dept Hematol, Tokyo, Japan
[11] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
[12] AOU Citta Salute & Sci Torino, Div Hematol, Myeloma Unit, Turin, Italy
[13] South Pest Cent Hosp, Natl Inst Hematol & Infect Dis, Dept Hematol & Stem Cell Transplantat, Budapest, Hungary
[14] Genentech Inc, San Francisco, CA 94080 USA
[15] AbbVie Inc, N Chicago, IL USA
[16] Mayo Clin, Rochester, MN USA
关键词
D O I
10.1182/blood-2019-126015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1888
引用
收藏
页数:5
相关论文
empty
未找到相关数据